This article relies largely or entirely on a single source. Relevant discussion may be found on the talk page. Please help improve this article by introducing citations to additional sources.Find sources: "TOMSO" – news · newspapers · books · scholar · JSTOR (December 2017)
TOMSO
Names
Preferred IUPAC name
1-[5-(Methanesulfinyl)-2-methoxy-4-methylphenyl]propan-2-amine
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C12H19NO2S/c1-8-5-11(15-3)10(6-9(2)13)7-12(8)16(4)14/h5,7,9H,6,13H2,1-4H3 checkY
    Key: LMQLBXOYCGXTOM-UHFFFAOYSA-N checkY
  • InChI=1/C12H19NO2S/c1-8-5-11(15-3)10(6-9(2)13)7-12(8)16(4)14/h5,7,9H,6,13H2,1-4H3
    Key: LMQLBXOYCGXTOM-UHFFFAOYAD
  • COC1=C(C=C(C(=C1)C)S(=O)C)CC(C)N
Properties
C12H19NO2S
Molar mass 241.35 g·mol−1
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
checkY verify (what is checkY☒N ?)

TOMSO (2-methoxy-4-methyl-5-methylsulfinylamphetamine) is a lesser-known psychedelic drug and a substituted amphetamine. TOMSO was first synthesized by Alexander Shulgin. In his book PiHKAL, the dosage range is listed as 100–150 mg, and the duration listed as 10–16 hours.[1] TOMSO is inactive on its own; it is activated with the consumption of alcohol. It produces intense time distortion and a threshold. Very little data exists about the pharmacological properties, metabolism, and toxicity of TOMSO.

See also

References

  1. ^ TOMSO entry in PiHKAL


Categories